Skip to main navigation Skip to search Skip to main content

ZUM AKTUELLEN STAND KLINISCHER PSYCHOPHARMAKOLOGIE

Translated title of the contribution: An up-date of clinical psychopharmacology

H. Grunze, F. Hohagen, H. J. Wark, T. Adam, M. Berger*

*Corresponding author for this work

Abstract

This paper deals with new trends in psychopharmacology. Our study on the incidence of psychiatric disorders on intensive care wards displays that basic knowledge about therapeutic profile, side-effects, and interaction with other drugs of recently released new drugs is also important for non-psychiatrics. We recall the serious side-effects of once or even still licensed drugs and present new therapeutic developments in the treatment of depression and psychosis.

Translated title of the contributionAn up-date of clinical psychopharmacology
Original languageGerman
JournalIntensivmedizin und Notfallmedizin
Volume29
Issue numberSUPPL. 1
Pages (from-to)30-41
Number of pages12
ISSN0175-3851
Publication statusPublished - 1992

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'An up-date of clinical psychopharmacology'. Together they form a unique fingerprint.

Cite this